DarioHealthDRIO
DRIO
About: DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Employees: 202
0
Funds holding %
of 7,312 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
11% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 9
8% more funds holding
Funds holding: 40 [Q4 2024] → 43 (+3) [Q1 2025]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]
2.6% less ownership
Funds ownership: 20.34% [Q4 2024] → 17.74% (-2.6%) [Q1 2025]
26% less capital invested
Capital invested by funds: $6.1M [Q4 2024] → $4.51M (-$1.59M) [Q1 2025]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
Low target
$3
317%
upside
Avg. target
$3
317%
upside
High target
$3
317%
upside
1 analyst rating
1 positive
100%
0 neutral
0%
0 negative
0%
Litchfield Hills Theodore O'Neill | 317%upside $3 | Buy Initiated | 19 May 2025 |
Financial journalist opinion
Neutral
PRNewsWire
2 weeks ago
Dario and GreenKey Health Announce Strategic Commercial Agreement to Transform Chronic Condition Management and Sleep Health for Payers Nationwide
Dario and GreenKey Join Forces to Target $150 Billion Sleep Apnea Market, Addressing 29 Million Americans with Unmet Needs Through Integrated Chronic Care Solution NEW YORK and SAN FRANCISCO , June 26, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ('Dario' or the 'Company'), a leader in the global digital health market, today announced a strategic commercial agreement with GreenKey Health ('GreenKey'), an innovator in value-based sleep health solutions, to bring the comprehensive care program to payers nationwide. The collaboration leverages the strengths of both companies to deliver a tiered, data-driven solution for improving member health outcomes, reducing healthcare costs, and enhancing productivity through the integration of behavioral health, sleep, and cardiometabolic care.
Neutral
PRNewsWire
2 weeks ago
Dario Unveils Groundbreaking GLP-1 and AI-Personalization Digital Health Findings
Dario's new research shows sustained outcomes post-GLP-1 for platform users and 89% accuracy in innovative AI blood glucose prediction; the Company is actively working to leverage these findings in commercial discussions NEW YORK , June 24, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced four new studies presented this past weekend at the 85th Annual American Diabetes Association ("ADA") Scientific Sessions in Chicago. The research, which represents Dario's 25th published study at the ADA's Scientific Sessions over the last decade, includes groundbreaking findings in sustaining GLP-1 weight loss and artificial intelligence ("AI")-powered personalization that highlight the Company's platform's critical contribution in the digital health market.
Neutral
Seeking Alpha
1 month ago
DarioHealth Corp. (DRIO) Q1 2025 Earnings Call Transcript
DarioHealth Corp. (NASDAQ:DRIO ) Q1 2025 Earnings Conference Call May 14, 2025 8:30 AM ET Company Participants Kat Parrella - Investor Relations Manager Erez Raphael - Chief Executive Officer Lara Dodo - Acting Chief Operating Officer Conference Call Participants Charles Yi - TD Securities David Grossman - Stifel Nicolaus Operator Good morning, ladies and gentlemen, and welcome to the DarioHealth First Quarter 2025 Results Conference Call. At this time, all lines are in a listen-only mode.
Negative
Zacks Investment Research
1 month ago
DarioHealth Corp. (DRIO) Reports Q1 Loss, Misses Revenue Estimates
DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.20 per share a year ago.
Neutral
PRNewsWire
1 month ago
DarioHealth Reports First Quarter 2025 Financial and Operating Results
First quarter revenue of $6.75 million, a 17% increase year-over-year, driven by employer and health plan (B2B2C) growth, and a decrease of 11% sequentially. Gross margin increased to 57.5% compared to 42.2% in the first quarter of 2024 Gross margin (non-GAAP) increased to 70.5%, up from 62.4% in the first quarter of 2024 Operating expenses decreased by 35% compared to the first quarter of 2024 and 16% sequentially, with additional efficiencies anticipated through ongoing AI-driven process optimization GAAP operating loss decreased by 47% compared to the first quarter of 2024, improving to $9.4 million Non-GAAP operating loss decreased by 36% compared to the first quarter of 2024, improving to $5.8 million 14 new clients signed year-to-date, including a national health plan, regional plan, 12 employers, and two pharma companies Strategic platform expansion through GLP-1 prescribing (MediOrbis), behavioral health (Rula), and cardiometabolic support via a national benefit plan administrator GLP-1 solution expanded with virtual prescribing and integration into chronic condition programs Artificial Intelligence (AI) transformation underway, automating workflows, lowering costs, and enhanced operational scalability Refinanced debt and raised equity, strengthening balance sheet, extending cash runway and providing operating flexibility to drive strategic plans Dario remains on track to achieve operational cash flow breakeven run rate by the end of 2025 given existing account expansion, new contract wins and a pipeline of near-term opportunities Dario will host an investor conference call and webcast at 8:30 a.m.
Neutral
PRNewsWire
2 months ago
Dario's Digital Health Solution Demonstrates Effectiveness in New Research Examining Flu Vaccination Awareness in High-Risk Populations
New data, published in JMIR, demonstrates the value of personalized messaging encouraging flu vaccinations in Dario members with diabetes NEW YORK , May 8, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today new research published in the Journal of Medical Internet Research ("JMIR") demonstrating the effectiveness of personalized digital health interventions to drive flu vaccine awareness in Dario members living with diabetes. People living with diabetes are at risk of severe complications from the flu, yet low awareness keeps many from receiving an influenza vaccination.
Neutral
PRNewsWire
2 months ago
DarioHealth to Report First Quarter 2025 Results on Wednesday, May 14, 2025
Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK , May 7, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today that it will release its financial results for the 1st quarter ended March 31 st, 2025 and will host a conference call and webcast at 8:30 a.m.
Neutral
PRNewsWire
2 months ago
DarioHealth Closes Strategic Refinancing of Existing Debt Facility of up to $50 Million to Provide Additional Operational Flexibility and Support Growth Initiatives
$32.5 million funded at close; up to $17.5 million of additional capital available at the Company's option, subject to the achievement of certain revenue thresholds. Capital from the transaction is expected to support execution of strategic plan and fuel continued growth.
Neutral
PRNewsWire
2 months ago
DarioHealth Announces CFO Transition
NEW YORK , April 21, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leading global digital health company, today announced that Zvi Ben-David , Chief Financial Officer, will retire from his role, effective May 15, 2025 . The Company has appointed Chen Franco-Yehuda as its new Chief Financial Officer, Treasurer, and Secretary, and will assume the role upon Mr.
Neutral
PRNewsWire
2 months ago
DarioHealth Collaborates with Leading National Benefit Plan Administrator to Offer Cardiometabolic Solution including a GLP-1 Support Program to Employers
Strategic partnership expands Dario's employer footprint and has already started contributing to recurring revenues in Q1 of 2025 NEW YORK , April 17, 2025 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced a new strategic partnership with a leading benefit administrator to deliver its comprehensive cardiometabolic solution including a GLP-1 support program and full AI-driven digital health suite to employers, with initial clients already implemented and contributing to revenue since January 2025. This marks Dario's first national benefit administrator partnership and represents a strategic step toward broader adoption across benefit administration channels.
Charts implemented using Lightweight Charts™